Amgenの内部者の所有権
Amgenの内部者の所有権は何ですか。
Amgen, Inc.の内部者の所有権は0.22%です。
内部者の所有権の定義は何ですか。
管理の所有権(Insider Ownership)は、発行済株式総数で除したインサイダー（5％超を所有する株主または取締役または役員) が所有する株式総数によって計算されます。
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
XETRAのセクタHealth Careにおける内部者の所有権の企業と比べるAmgen
Amgenは何をしますか。
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Amgenと類似の内部者の所有権
- The Travelers Companiesの内部者の所有権は0.22%です。
- NB Private Equity Partnersの内部者の所有権は0.22%です。
- Weyerhaeuser Coの内部者の所有権は0.22%です。
- NB Private Equity Partnersの内部者の所有権は0.22%です。
- CTI BioPharma Corpの内部者の所有権は0.22%です。
- Signify N.Vの内部者の所有権は0.22%です。
- Amgenの内部者の所有権は0.22%です。
- Xilinxの内部者の所有権は0.22%です。
- Xilinxの内部者の所有権は0.22%です。
- Xilinxの内部者の所有権は0.22%です。
- Northrop Grummanの内部者の所有権は0.22%です。
- Fox Factory Corpの内部者の所有権は0.22%です。
- CSXの内部者の所有権は0.22%です。